ENDUROBOLGW501516;CARDARINE CAS:317318-70-0

CAS NO: 317318-70-0
ENDUROBOLGW501516;CARDARINE CAS:317318-70-0
Description Review
Description

GW501516, also known as Cardarine, is a peroxisome proliferator-activated receptor delta (PPARδ) agonist that is known for its ability to increase endurance, improve cardiovascular health, and enhance fat burning. This non-steroidal compound works by increasing the uptake of glucose in the muscles, leading to increased energy levels and improved athletic performance.

Top Searched Keywords on Google and Synonyms on google:

Cardarine Endurobol GSK-516 GW1516 Peroxisome proliferator-activated receptor delta agonist

Health Benefits:

GW501516 is known to have several health benefits, including increased endurance, improved cardiovascular health, enhanced fat burning, and improved metabolic function. Additionally, it has been found to improve overall well-being, increase energy levels, and decrease the risk of serious medical conditions such as diabetes and heart disease.

Potential Effects:

GW501516 is known to have potent endurance-enhancing effects, making it a popular choice among athletes and fitness enthusiasts. It has been shown to increase endurance, improve cardiovascular health, and enhance fat burning. Additionally, it has been found to improve metabolic function, reduce inflammation, and improve overall health and well-being.

Mechanisms:

GW501516 works by increasing the uptake of glucose in the muscles, leading to increased energy levels and improved athletic performance. Additionally, it stimulates the production of new mitochondria, which are responsible for producing energy in the body. This results in increased endurance, improved cardiovascular health, and enhanced fat burning.

Safety:

While GW501516 has been found to be generally safe, there are some potential side effects that should be considered before use. These include an increase in liver enzymes, an increase in blood pressure, and changes in cholesterol levels. Additionally, it has been found to cause cancer in animal studies, and as such, it should only be used under the guidance of a qualified medical professional.

Side-Effects:

Some potential side effects associated with GW501516 include an increase in liver enzymes, an increase in blood pressure, changes in cholesterol levels, and an increased risk of cancer.

Dosage Information:

The recommended dosage of GW501516 varies depending on the intended use. For endurance-enhancing purposes, a dosage of 10mg per day is typically recommended. However, these dosages should only be used under the guidance of a qualified medical professional to ensure maximum safety and effectiveness.

In conclusion, GW501516 is a potent and effective non-steroidal compound that has been found to have several health benefits, including increased endurance, improved cardiovascular health, and enhanced fat burning. While it is generally safe, potential side effects should be considered before use, and it should only be used under the guidance of a qualified medical professional.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code